Your browser doesn't support javascript.
loading
Angiotensin Receptor-Neprilysin Inhibitor Therapy and Cardiac Remodeling in Heart Failure: Consensus Statement from India.
Chopra, H K; Wander, G S; Nair, Tiny; Ponde, C K; Nanda, Navin C; Narula, Jagat; Ray, Saumitra; Venugopal, K; Iyengar, S S; Kasliwal, R R; Chandra, Praveen; Prakash, Sunil; Bansal, Sandeep; Rana, D S; Kerkar, Prafulla; Dasbiswas, Arup; Sawhney, Jps; Shanmungasundram, S; Kumar, Viveka; Vijayalakshmi, I B; Pancholia, A K; Sharma, Vinod; Kapoor, Aditya; Swami, Onkar C; Isser, H S; Rastogi, Vishal; Arora, Y K; Omar, Ashok K; Sathe, Sunil; Rajput, Rajeeve; Prabhakar, D; Paul, G Justin; Jagia, Priya; Malhotra, Poonam; Suryaprakash, G; Mittal, Vinod; Jagia, Manish; Jabir, A; Mishra, S S; Routray, S N; Sinha, Ajay Kumar; Bhargava, Mohan; Mahmood, Kiran; Lal, Shreya; Dabhade, Dhammdeep; Bhatia, Mona; Kalra, Pramila; Katyal, V K; Tandon, Rohit; Grover, Rahul.
Afiliación
  • Chopra HK; Senior Consultant, Department of Cardiology, Medanta Moolchand Heart Center, Delhi.
  • Wander GS; Professor and Head, Department of Cardiology, Dayanand Medical College and Hospital, Ludhiana, Punjab;Corresponding Author.
  • Nair T; Head, Department of Cardiology, PRS Hospital, Trivandrum, Kerala.
  • Ponde CK; Consultant Cardiologist and Head, Department of Cardiology, PD Hinduja National Hospital & Medical Research Centre, Mumbai, Maharashtra, India.
  • Nanda NC; Department of Cardiology Division, University of Alabama at Birmingham (UAB), Birmingham, Alabama.
  • Narula J; Associate Dean, Chief, Icahn School of Medicine at Mount Sinai (ISMMS); Division of Cardiology, Mount Sinai Hospital, New York, United States of America.
  • Ray S; Director, Department of Invasive Cardiology, AMRI Hospital, Kolkata, West Bengal.
  • Venugopal K; Senior Consultant Cardiologist, KVM Hospital Cherthala and SP Fort Hospital, Thiruvananthapuram, Kerala.
  • Iyengar SS; Consultant Emeritus and Academic Head, Department of Cardiology, Manipal Hospital, Bengaluru, Karnataka.
  • Kasliwal RR; Chairman, Department of Clinical and Preventive Cardiology, Medanta The Medicity, Gurugram, Haryana.
  • Chandra P; Chairman, Department of Interventional and Structural Heart Cardiology, Medanta The Medicity, Gurugram, Haryana.
  • Prakash S; Senior Director and Head, Department of Nephrology and Renal Transplantation, BLK-Max Super Speciality Hospital, Delhi.
  • Bansal S; Consultant in Cardiology, Professor and Head, Department of Cardiology, Vardhaman Mahavir Medical College and Safdarjung Hospital, Delhi.
  • Rana DS; Chairman, Department of Nephrology, Sir Ganga Ram Hospital, Delhi.
  • Kerkar P; Senior Consultant Interventional Cardiologist, Asian Heart Institute, Mumbai, Maharashtra.
  • Dasbiswas A; Ex Director ICVS, Professor and Head of Department, Department of Cardiology, ICVS; Institute of Postgraduate Medical Education & Research, Kolkata, West Bengal.
  • Sawhney J; Chief of Clinical and Preventive Cardiology, Chairman, Department of Cardiology, Sir Gangaram Hospital, Delhi.
  • Shanmungasundram S; Senior Cardiologist, Billroth Hospitals, Chennai, Tamil Nadu.
  • Kumar V; Principal Director and Chief of Cath Labs (Pan Max), Department of Cardiac Sciences, Max Hospital, Delhi.
  • Vijayalakshmi IB; Professor Emeritus, Former Head Pediatric Cardiology, Shri Jayadeva Institute of Cardiovascular sciences and Research, Bengaluru, Karnataka.
  • Pancholia AK; Head of Department, Department of Clinical and Preventive Cardiology, Arihant Hospital and Research Centre, Indore, Madhya Pradesh.
  • Sharma V; Head of Cardiology and Vice Chief Executive Officer, National Heart Institute, Delhi.
  • Kapoor A; Head, Department of Cardiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh.
  • Swami OC; Director, Department of Medical Services, Emcure Pharmaceuticals Ltd., Pune, Maharashtra.
  • Isser HS; Professor and Consultant, Department of Cardiology, Vardhman Mahavir Medical College and Safdarjung Hospital.
  • Rastogi V; Director, Department of Interventional Cardiology, Head of Advanced Heart Failure Program, Fortis Escort Heart Institute.
  • Arora YK; Consultant Cardiologist, National Heart Institute.
  • Omar AK; Director, Noninvasive Cardiology and Head Heart Command Centres, Fortis Escorts Heart Institute, Delhi.
  • Sathe S; Interventional Cardiologist, Ruby Hall Clinic, Pune, Maharashtra.
  • Rajput R; Senior Consultant Cardiologist, Apollo Hospitals, Delhi.
  • Prabhakar D; Consultant Interventional Cardiologist, Ashwin Clinic, Chennai, Tamil Nadu.
  • Paul GJ; Professor of Cardiology, Madras Medical College, Chennai, Tamil Nadu.
  • Jagia P; Professor and Head, Department of Cardiovascular Imaging and Endovascular Interventions, Cardiothoracic Sciences Centre, All India Institute of Medical Sciences, Delhi.
  • Malhotra P; Senior Professor, Cardiac Anaesthesia, All India Institute of Medical Sciences, Delhi.
  • Suryaprakash G; Senior Consultant Cardiologist and Clinical Director, Care Hospitals, Hyderabad, Telangana.
  • Mittal V; Senior Consultant Diabetologist and Head, Centre for Diabetes and Metabolic Diseases, Delhi Heart and Lung Institute.
  • Jagia M; Director, Department of Anaesthesia and Critical care, Moolchand Hospital, Delhi.
  • Jabir A; Senior Cardiologist and Assistant Professor, Lisie Hospital, Cochin, Kerala.
  • Mishra SS; Director and Senior Consultant Cardiologist, Med N Heart Clinic, Cuttack, Odisha.
  • Routray SN; Professor and Head, Department of Cardiology, SCB Medical College, Cuttack, Odisha.
  • Sinha AK; Senior Consultant, Department of Cardiology, Medanta Heart Institute, Patna, Bihar.
  • Bhargava M; Director of Cardiology and Interventional Cardiologist, Max hospital, Delhi, India.
  • Mahmood K; Assistant Professor of Medicine (Cardiology), Icahn School of Medicine at Mount Sinai (ISMMS); Director of Heart Failure Program, Mount Sinai Morningside Hospital, New York, United States of America.
  • Lal S; Deputy Manager.
  • Dabhade D; Senior Manager, Department of Medical Services, Emcure Pharmaceuticals Ltd., Pune, Maharashtra.
  • Bhatia M; Principal Director and Head, Department of Radiology and Imaging, Fortis Escorts Heart Institute, Delhi.
  • Kalra P; Professor and Head, Department of Endocrinology, Ramaiah Medical College and Hospitals, Bengaluru, Karnataka.
  • Katyal VK; Head of Department, Department of Medicine, Positron Multispecialty and Cancer Hospital, Rohtak, Haryana.
  • Tandon R; Consultant, Department of Cardiology, Dayanand Medical College and Hospital, Ludhiana, Punjab.
  • Grover R; Associate Director, Department of Nephrology, Max Hospital, Delhi.
J Assoc Physicians India ; 71(4): 11-12, 2023 Apr.
Article en En | MEDLINE | ID: mdl-37355795
ABSTRACT
Adverse cardiac remodeling refers to progressive structural and functional modifications in the heart because of increased wall stress in the myocardium, loss of viable myocardium, and neurohormonal stimulation. The guideline-directed medical therapy for Heart failure (HF) includes Angiotensin receptor-neprilysin inhibitor (ARNI) (sacubitril/valsartan), ß-blockers, sodium-glucose co-transporter 2 (SGLT2) inhibitors, and mineralocorticoid receptor antagonists (MRA). ARNI is under-prescribed in India despite its attractive safety and efficacy profile. Therefore, the consensus discusses objectives and topics related to ARNI in the management of cardiac remodeling, and experts shared their views on the early timely intervention of effective dosage of ARNI to improve the diagnosis and enhance mortality and morbidity benefits in cardiac reverse remodeling (CRR).
Asunto(s)
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases / 6_other_circulatory_diseases Asunto principal: Neprilisina / Insuficiencia Cardíaca Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: J Assoc Physicians India Año: 2023 Tipo del documento: Article
Buscar en Google
Añadir a Mi BVS
Imprimir
XML
PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_cardiovascular_diseases / 6_other_circulatory_diseases Asunto principal: Neprilisina / Insuficiencia Cardíaca Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: J Assoc Physicians India Año: 2023 Tipo del documento: Article